Koppers (KOP) Stock Forecast & Price Target

Koppers Holdings Inc. demonstrated strong financial performance, with adjusted EBITDA rising by 78.1% to $5.04 million and gross profit increasing by 43.7% to $12.2 million, reflecting improved operational efficiency. The company's total revenue grew by 41.6%, driven by substantial increases in its Pharma segment and average quarterly revenue per program, which surged 52% to $75,434. Additionally, projections for an 11% revenue increase in the Performance Chemicals segment by 2026 indicate a positive trajectory for market share expansion, further bolstering the company's financial outlook.

Koppers Holdings Inc experienced a significant decline in consolidated sales of 9.3% in Q4 2025, with total annual sales falling to $1.9 billion, a 10% drop from the previous year. The company's Railroad and Utility Products and Services segment reported a year-over-year sales decrease of 3.2%, indicating potential challenges in its primary revenue-generating area. Additionally, the outlook for adjusted EBITDA has been negatively impacted, with expectations for its Carbon Materials and Chemicals segment revised down from $28 million to $17.5 million, mainly due to concerns over market softness and lower performance in the Catalyst transformation process.